Burrows GG[au] - Search Results

Year	Number of Results
1989	1
1993	2
1994	1
1996	2
1997	1
1998	2
1999	1
2000	3
2001	2
2003	3
2004	6
2005	5
2006	4
2007	2
2008	2
2009	3
2010	6
2011	5
2012	5
2013	5
2014	2
2015	1
2018	1
2022	0

1

Treatment of autoimmune anterior uveitis with recombinant TCR ligands.

Adamus G, Burrows GG, Vandenbark AA, Offner H. Adamus G, et al. Among authors: burrows gg. Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2555-61. doi: 10.1167/iovs.05-1242. Invest Ophthalmol Vis Sci. 2006. PMID: 16723470

2

Systemic immunomodulation of autoimmune disease using MHC-derived recombinant TCR ligands.

Burrows GG. Burrows GG. Curr Drug Targets Inflamm Allergy. 2005 Apr;4(2):185-93. doi: 10.2174/1568010053586363. Curr Drug Targets Inflamm Allergy. 2005. PMID: 15853741 Free PMC article. Review.

3

Gilt required for RTL550-CYS-MOG to treat experimental autoimmune encephalomyelitis.

Burrows GG, Meza-Romero R, Huan J, Sinha S, Mooney JL, Vandenbark AA, Offner H. Burrows GG, et al. Metab Brain Dis. 2012 Jun;27(2):143-9. doi: 10.1007/s11011-012-9289-7. Epub 2012 Mar 7. Metab Brain Dis. 2012. PMID: 22392628 Free PMC article.

4

Recombinant T cell receptor ligands: immunomodulatory, neuroprotective and neuroregenerative effects suggest application as therapy for multiple sclerosis.

Offner H, Sinha S, Wang C, Burrows GG, Vandenbark AA. Offner H, et al. Among authors: burrows gg. Rev Neurosci. 2008;19(4-5):327-39. doi: 10.1515/revneuro.2008.19.4-5.327. Rev Neurosci. 2008. PMID: 19145988 Free PMC article. Review.

5

Human TCR as antigen: homologies and potentially cross-reactive HLA-DR2-restricted epitopes within the AV and BV CDR2 loops.

Vandenbark AA, Culbertson N, Finn T, Barnes D, Buenafe A, Burrows GG, Law S, Chou YK, Offner H. Vandenbark AA, et al. Among authors: burrows gg. Crit Rev Immunol. 2000;20(1):57-83. Crit Rev Immunol. 2000. PMID: 10770270 Review.

6

RTL therapy for multiple sclerosis: a Phase I clinical study.

Offner H, Sinha S, Burrows GG, Ferro AJ, Vandenbark AA. Offner H, et al. Among authors: burrows gg. J Neuroimmunol. 2011 Feb;231(1-2):7-14. doi: 10.1016/j.jneuroim.2010.09.013. Epub 2010 Oct 20. J Neuroimmunol. 2011. PMID: 20965577 Free PMC article. Clinical Trial.

7

MHC class I loaded ligands from breast cancer cell lines: A potential HLA-I-typed antigen collection.

Rozanov DV, Rozanov ND, Chiotti KE, Reddy A, Wilmarth PA, David LL, Cha SW, Woo S, Pevzner P, Bafna V, Burrows GG, Rantala JK, Levin T, Anur P, Johnson-Camacho K, Tabatabaei S, Munson DJ, Bruno TC, Slansky JE, Kappler JW, Hirano N, Boegel S, Fox BA, Egelston C, Simons DL, Jimenez G, Lee PP, Gray JW, Spellman PT. Rozanov DV, et al. Among authors: burrows gg. J Proteomics. 2018 Mar 30;176:13-23. doi: 10.1016/j.jprot.2018.01.004. Epub 2018 Jan 10. J Proteomics. 2018. PMID: 29331515 Free PMC article.

8

Decreased FOXP3 levels in multiple sclerosis patients.

Huan J, Culbertson N, Spencer L, Bartholomew R, Burrows GG, Chou YK, Bourdette D, Ziegler SF, Offner H, Vandenbark AA. Huan J, et al. Among authors: burrows gg. J Neurosci Res. 2005 Jul 1;81(1):45-52. doi: 10.1002/jnr.20522. J Neurosci Res. 2005. PMID: 15952173 Clinical Trial.

9

Partial MHC class II constructs inhibit MIF/CD74 binding and downstream effects.

Benedek G, Meza-Romero R, Andrew S, Leng L, Burrows GG, Bourdette D, Offner H, Bucala R, Vandenbark AA. Benedek G, et al. Among authors: burrows gg. Eur J Immunol. 2013 May;43(5):1309-21. doi: 10.1002/eji.201243162. Epub 2013 Apr 10. Eur J Immunol. 2013. PMID: 23576302 Free PMC article.

10

Human multipotent adult progenitor cells transcriptionally regulate fucosyltransferase VII.

Burrows GG, Maziarz RT, Hunady K, Lehman N, Raber A, Deans RJ, Van't Hof W. Burrows GG, et al. Cytotherapy. 2014 Apr;16(4):566-75. doi: 10.1016/j.jcyt.2013.08.004. Epub 2013 Oct 29. Cytotherapy. 2014. PMID: 24176542

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results